About James Small
Form D filings for Provell Pharmaceuticals from 2013 to 2024 list James Small as executive officer.
James Small first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name James Small in the role, so the role may have started earlier or lasted longer.